Depression: meeting study criteria for depression at end of · people with depression after stroke
It is very uncertain whether pharmacological interventions changes depression: meeting study criteria for depression at end of… compared with placebo (very low certainty).
2 findings from 1 review
Depression: < 50% reduction in scale scores at end of treatment (primary outcome) · people with depression after stroke
It is very uncertain whether pharmacological interventions changes depression: < 50% reduction in scale scores at end of treatment… compared with placebo (very low certainty).
1 finding from 1 review
Depression: mean scores at end of treatment (secondary outcome) · people with depression after stroke
1 finding from 1 review
Adverse events: death ‐ at end of treatment (secondary outcome) · people with depression after stroke
It is very uncertain whether pharmacological interventions changes adverse events: death (secondary outcome) compared with placebo (very low certainty).
1 finding from 1 review
Adverse effects (central nervous system) · people with depression after stroke
It is very uncertain whether pharmacological interventions changes adverse events: all ‐ central nervous system events (e.g. confusion,… compared with placebo (very low certainty).
1 finding from 1 review
Gastrointestinal adverse events · people with depression after stroke
It is very uncertain whether pharmacological interventions changes adverse events: all ‐ gastrointestinal effects (e.g. constipation,… compared with placebo (very low certainty).
1 finding from 1 review
Effect on later sexual function · men (aged between 23 and 45) with premature ejaculation within 3 months after stroke
1 finding from 1 review
Sexual satisfaction · men (aged between 23 and 45) with premature ejaculation within 3 months after stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Secondary outcome: quality of life · men (aged between 23 and 45) with premature ejaculation within 3 months after stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Psychological well‐being (secondary outcome) Not addressed · men (aged between 23 and 45) with premature ejaculation within 3 months after stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Satisfaction with intervention (secondary outcome) Not addressed · men (aged between 23 and 45) with premature ejaculation within 3 months after stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Marital/relationship/partner satisfaction (secondary outcome) · men (aged between 23 and 45) with premature ejaculation within 3 months after stroke
1 finding from 1 review
Secondary outcome: all adverse events · men (aged between 23 and 45) with premature ejaculation within 3 months after stroke
1 finding from 1 review
GABA analogue VAS(0 to 10 cm) · uraemic pruritus
1 finding from 1 review
Montelukast Duo score (0 to 81) and VAS (0 to 10 cm) · uraemic pruritus
1 finding from 1 review
Sertraline VAS(0 to 10 cm) · uraemic pruritus
1 finding from 1 review
Lidocaine Itch relief · uraemic pruritus
1 finding from 1 review
Sodium thalidomide Itch relief · uraemic pruritus
1 finding from 1 review
Doxepin Itch relief · uraemic pruritus
1 finding from 1 review
Ondansetron VAS(0 to 10 cm) · uraemic pruritus
1 finding from 1 review